메뉴 건너뛰기
Psychopharmacology
Volumn 142, Issue 2, 1999, Pages 209-214
The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats
Author keywords

Antinociception; NMDA antagonists; Opioid; Tail withdrawal Tolerance
Indexed keywords

DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; MORPHINE;
EID: 0032932674     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050881     Document Type: Article
Times cited : (28)
References (9)
  • 1
    • 26444542215 scopus 로고    scopus 로고
    • The competitive NMDA receptor antagonist LY235959 attenuates but does not reverse morphine tolerance in a rat tail-withdrawal procedure
    • Allen RM, Dykstra LA (1997) The competitive NMDA receptor antagonist LY235959 attenuates but does not reverse morphine tolerance in a rat tail-withdrawal procedure. Soc Neurosci Abstr 23:70.6
    • (1997) Soc Neurosci Abstr , vol.23
    • Allen, R.M.1    Dykstra, L.A.2
  • 2
    • 0030444685 scopus 로고    scopus 로고
    • Competitive and non-competitive NMDA antagonists block the development of tolerance to morphine, but not to selective μ or δ opioid agonists in mice
    • Bilsky EJ, Inturrisi CE, Sadee W, Hruby VJ, Porrecca F (1996) Competitive and non-competitive NMDA antagonists block the development of tolerance to morphine, but not to selective μ or δ opioid agonists in mice. Pain 68:229-237
    • (1996) Pain , vol.68 , pp. 229-237
    • Bilsky, E.J.1    Inturrisi, C.E.2    Sadee, W.3    Hruby, V.J.4    Porrecca, F.5
  • 3
    • 0028609062 scopus 로고
    • Dextromethorphan attenuates and reverses analgesic tolerance to morphine
    • Elliott K, Hynansky A, Inturrisi CE (1994) Dextromethorphan attenuates and reverses analgesic tolerance to morphine. Pain 59:361-368
    • (1994) Pain , vol.59 , pp. 361-368
    • Elliott, K.1    Hynansky, A.2    Inturrisi, C.E.3
  • 4
    • 0029562938 scopus 로고
    • The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: Medication development issues for opiate addiction
    • Herman BH, Vocci F, Bridge P (1995) The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: Medication development issues for opiate addiction. Neuropsychopharmacology 13:269-294
    • (1995) Neuropsychopharmacology , vol.13 , pp. 269-294
    • Herman, B.H.1    Vocci, F.2    Bridge, P.3
  • 5
    • 0031443288 scopus 로고    scopus 로고
    • The competitive α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids
    • Kest B, McLemore G, Kao B, Inturrisi CE (1997) The competitive α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids. J Pharmacol Exp Ther 283:1249-1255
    • (1997) J Pharmacol Exp Ther , vol.283 , pp. 1249-1255
    • Kest, B.1    McLemore, G.2    Kao, B.3    Inturrisi, C.E.4
  • 6
    • 0027283378 scopus 로고
    • Blockade of tolerance to morphine but not to K opioids by a nitric oxide synthase inhibitor
    • Kolesnikov YA, Pick CG, Ciszewska G, Pasternak GW (1993) Blockade of tolerance to morphine but not to K opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 90: 5162-5166
    • (1993) Proc Natl Acad Sci USA , vol.90 , pp. 5162-5166
    • Kolesnikov, Y.A.1    Pick, C.G.2    Ciszewska, G.3    Pasternak, G.W.4
  • 7
    • 0027980235 scopus 로고
    • 1-Aminocarboxylic acid (ACPC) prevents mu and delta opioid tolerence
    • Kolesnikov YA, Maccechini M, Pasternak GW (1994) 1-Aminocarboxylic acid (ACPC) prevents mu and delta opioid tolerence. Life Sci 55:1393-1398
    • (1994) Life Sci , vol.55 , pp. 1393-1398
    • Kolesnikov, Y.A.1    Maccechini, M.2    Pasternak, G.W.3
  • 8
    • 0027441980 scopus 로고
    • Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-Aspartate receptor antagonist, LY274614
    • Tiseo PJ, Inturrisi CE (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-Aspartate receptor antagonist, LY274614. J Pharmacol Exp Ther 264:1090-1096
    • (1993) J Pharmacol Exp Ther , vol.264 , pp. 1090-1096
    • Tiseo, P.J.1    Inturrisi, C.E.2
  • 9
    • 0027958224 scopus 로고
    • Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614: Assessment of opioid receptor changes
    • Tiseo PJ, Cheng J, Pasternak GW, Inturrisi CE (1994) Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614: assessment of opioid receptor changes. J Pharmacol Exp Ther 268:195-201
    • (1994) J Pharmacol Exp Ther , vol.268 , pp. 195-201
    • Tiseo, P.J.1    Cheng, J.2    Pasternak, G.W.3    Inturrisi, C.E.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.